glutathione lpt Evexias Wellness & Energy Bundle

CELLg8 has developed a liposomal delivery technology that creates very small and stable liposomes, improving the absorption of the liposomes and their contents

Myoinositol supplementation for the prevention of gestational diabetes in at-risk patients

Liposomal delivery protects NAD+ through digestion Helps it pass first-pass metabolism and reach the bloodstream Improves absorption compared to standard oral forms This is why he focuses specifically on liposomal NAD+ in his routine

TROPiCS-03 (NCT03964727) is a phase II basket trial evaluating SG in patents with metastatic or locally advanced solid tumors

Haematological parameters typically normalise within approximately 8 weeks of appropriate treatment